DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Lesogaberan is an investigational drug.
There have been 8 clinical trials for Lesogaberan. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2007.
The most common disease conditions in clinical trials are Gastroesophageal Reflux, Heartburn, and Renal Insufficiency. The leading clinical trial sponsors are AstraZeneca, National Taiwan University Hospital, and Ministry of Science and Technology, Taiwan.
Recent Clinical Trials for Lesogaberan
|Lesogaberan in Chinese Patients With Refractory Reflux Symptoms||Ministry of Science and Technology, Taiwan||Phase 2|
|Lesogaberan in Chinese Patients With Refractory Reflux Symptoms||National Taiwan University Hospital||Phase 2|
|Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPI||AstraZeneca||Phase 2|